This is a working overview of nasal formulation, written for readers who want more than a one-paragraph summary but less than a textbook.
This page was last updated on 2026-08-01 and is reviewed periodically as new material appears.
Development took place during the 1980s at institutes of the Russian Academy of Sciences, where peptide fragments of ACTH were screened for cognitive and neuroprotective effects. The compound received regulatory approval in Russia as a nasal preparation, marketed for conditions such as ischemic stroke, transient ischemic attacks, and optic nerve disorders. Registration in other countries has not followed. Most published clinical reports originate from a small number of Russian research groups, and independent replication outside that setting remains limited. The regulatory status therefore differs sharply between Russia and the rest of the world.
Laboratory work points toward modulation of neurotrophic signaling, particularly expression of brain-derived neurotrophic factor and nerve growth factor in hippocampal tissue. Studies also describe effects on monoamine turnover, inflammatory mediators, and oxidative markers. These observations come mainly from animal models and cultured cells, so the causal chain in humans is not firmly established. Whether the reported molecular changes translate into measurable clinical benefit is an open question. Reviews generally present the mechanism as plausible rather than demonstrated.
Development of the compound took place in the Soviet Union during the 1980s, largely through peptide research groups affiliated with the Shemyakin-Ovchinnikov Institute and Moscow State University. Investigators screened fragments of adrenocorticotropic hormone for activity on the central nervous system while attempting to separate cognitive effects from hormonal ones. The shortened sequence was selected because it retained behavioral activity in animal models without stimulating corticosteroid release. Early publications described the molecule as an ACTH(4-10) analog.
Published research on this peptide originates mainly from Russian laboratories, and the wider international literature is comparatively thin. Studies have used rodent models of stroke, hypoxia, and memory tasks, with a smaller number of human trials reported. Reported outcomes include changes in attention and memory measures, along with effects on neurotrophic factor expression in some experiments. Small sample sizes, inconsistent dosing protocols, and limited independent replication are widely noted limitations, so the strength of the clinical evidence remains an open question.
| Property | Value | Notes |
|---|---|---|
| Sequence | Met-Glu-His-Phe-Pro-Gly-Pro | Heptapeptide; ACTH(4-10) analog extended at C-terminus |
| Molecular mass | ~813.9 Da | Free peptide, unmodified |
| Appearance | White to off-white powder | Typical lyophilized solid |
| Solubility | Soluble in water and saline | Also soluble in common aqueous buffers |
| Storage (solid) | -20 °C, desiccated | Protect from moisture and repeated thawing |
=== Harm assessment === Professor David Nutt, former chair of the Advisory Council on the Misuse of Drugs (ACMD) in the UK has said in 2009, "people are better off taking ecstasy or amphetamines than those [drugs] we know nothing about" and "Who knows what's in [mephedrone] when you buy it? We don't have a testing system. It could be very dangerous[;] we just don't know. These chemicals have never been put into animals, let alone humans." Les King, a former member of the ACMD, has stated mephedrone appears to be less potent than amphetamine and ecstasy, but that any benefit associated with this could be negated by users taking larger amounts. He also told the BBC, "all we can say is [mephedrone] is probably as harmful as ecstasy and amphetamines and wait until we have some better scientific evidence to support that."
The American Society for Biochemistry and Molecular Biology (ASBMB) is a learned society that was founded on December 26, 1906, at a meeting organized by John Jacob Abel (Johns Hopkins University). The roots of the society were in the American Physiological Society, which had been formed some 20 years earlier. ASBMB is the US member of the International Union of Biochemistry and Molecular Biology. The ASBMB was originally called the American Society of Biological Chemists, before obtaining its current name in 1987. The society is based in Rockville, Maryland. ASBMB's mission is to advance the science of biochemistry and molecular biology through publication of scientific and educational journals, the organization of scientific meetings, advocacy for funding of basic research and education, support of science education at all levels, and by promoting the diversity of individuals entering the scientific workforce. The organization currently has over 12,000 members.
The magnetic mass separators are able to separate isobars by mass number, however they are unable to sort isotopes of the same mass. If an experiment requires a higher degree of chemical purity, it will need the beam to have an additional separation, by proton number. RILIS provides this separation by using step-wise resonance photo-ionisation, involving precisely tuned laser wavelengths matched exactly to a specific element's successive electron transition energies. Ionisation will only occur of the desired element, and the other elements within the ion-source will remain unchanged. This process of laser ionisation takes place in a hot metal cavity to provide the spatial confinement needed for the atomic vapour to be illuminated. A high frequency laser system is needed to ionise the atom before it leaves the cavity. All in all, the ISOLDE facility provides 1300 isotopes from 75 elements in the periodic table.
Promethium (61Pm) is an artificial element, except in trace quantities as a product of spontaneous fission of 238U and 235U and alpha decay of 151Eu, and thus a standard atomic weight cannot be given. Like all artificial elements, it has no stable isotopes. It was first synthesized in 1945. Like technetium, it is preceded and followed by elements with stable isotopes. The known isotopes run from 128Pm to 166Pm, 39 in all; the most stable are 145Pm with a half-life of 17.7 years, 146Pm with a half-life of 5.53 years, and 147Pm (the common isotope) with a half-life of 2.6234 years. 143Pm and 144Pm also have lengthy if poorly-known lives on the order of a year, but all the others have half-lives that are less than six days, with the majority less than a few minutes. There are also 24 known meta states with the most stable being 148mPm at a half-life of 41.29 days. The primary decay mode for isotopes lighter than 146Pm is electron capture resulting in isotopes of neodymium, and the primary decay mode heavier than 146Pm is beta decay giving isotopes of samarium; promethium-146 itself decays both ways.
Sources: en.wikipedia.org
== See also == AFGROW – Fracture mechanics and fatigue crack growth analysis software Concrete cone failure – Failure mode of anchors in concrete submitted to tensile force Concrete degradation – Damage to concrete affecting its mechanical strength and its durability Earthquake – Sudden movement of the Earth's crust Fatigue – Initiation and propagation of cracks in a material due to cyclic loading Fault (geology) – Fracture or discontinuity in displaced rock Material failure theory – Science of predicting if, when, and how a given material will fail under loading Notch (engineering) – Externally-produced indentation in a planar material Peridynamics – Non-local formulation of continuum mechanics, a formulation of continuum mechanics that is oriented toward deformations with discontinuities, especially fractures Shock (mechanics) – Sudden transient acceleration Strength of materials Stress corrosion cracking – Growth of cracks in a corrosive environment Structural fracture mechanics – Field of structural engineering
A 2023 meta-analysis of 16 RCTs found that transcranial direct current stimulation (tDCS) of over 4 weeks can decrease pain in patients with fibromyalgia. A 2021 meta-analysis of multiple intervention types concluded that magnetic field therapy and transcranial magnetic stimulation may diminish pain in the short-term, but conveyed an uncertainty about the relevance of the result. Several 2022 meta-analyses focusing on transcranial magnetic stimulation found positive effects on fibromyalgia. Repetitive transcranial magnetic stimulation improved pain in the short-term and quality of life after 5–12 weeks. Repetitive transcranial magnetic stimulation did not improve anxiety, depression, and fatigue. Transcranial magnetic stimulation to the left dorsolateral prefrontal cortex was also ineffective. A systematic review of EEG neurofeedback for the treatment of fibromyalgia found most treatments showed significant improvements of the main symptoms of the disease. However, the protocols were so different, and the lack of controls or randomization impede drawing conclusive results.
As the surface of the sensor shears through the liquid, energy is lost due to its viscosity. This dissipated energy is then measured and converted into a viscosity reading. A higher viscosity causes a greater loss of energy. Extensional viscosity can be measured with various rheometers that apply extensional stress. Volume viscosity can be measured with an acoustic rheometer. Apparent viscosity is a calculation derived from tests performed on drilling fluid used in oil or gas well development. These calculations and tests help engineers develop and maintain the properties of the drilling fluid to the specifications required. Nanoviscosity (viscosity sensed by nanoprobes) can be measured by fluorescence correlation spectroscopy.
Pardee (1912), neurologist, husband of Abby Rockefeller Alfred Sturtevant (1912), geneticist, protege of Thomas Hunt Morgan and winner of the National Medal of Science James Chapin (1916), ornithologist; 17th president of The Explorers Club Seeley G. Mudd (1917), physician and philanthropist, former dean of Keck School of Medicine of USC Harold Alexander Abramson (1919), early advocate of Psychedelic therapy Augustus Braun Kinzel (1919), metallurgist and first president of the National Academy of Engineering William V. Silverberg (1919), founder of the American Academy of Psychoanalysis and Dynamic Psychiatry Sherman Fairchild* (1920), founder of Fairchild Aircraft, Fairchild Industries, Fairchild Camera and Instrument as well as Fairchild Semiconductor Francis Bitter (1925), physicist, inventor of Bitter electromagnets Howard Bruenn (1925), personal physician to Franklin D. Roosevelt Albert Charles Smith (1926), botanist, former director of the National Museum of Natural History and the Arnold Arboretum Konrad Lorenz* (1926), winner of the Nobel Prize in Physiology or Medicine Jerrold R. Zacharias (1926), nuclear physicist, professor at Massachusetts Institute of Technology Andrew Streitwieser (1927), chemist known for his contributions to physical organic chemistry Julian M. Sturtevant (1927), chemist at Yale University Raymond D.
An antibody elution is a clinical laboratory diagnostic procedure which removes sensitized antibodies from red blood cells, in order to determine the blood group system antigen the antibody targets. An antibody elution is deemed necessary when antibodies of the immunoglobulin class G (IgG) are found sensitized (bound) to peripheral red cells collected from a blood product transfusion recipient. IgG antibodies are detected using an assay known as the direct antiglobulin test. Antibody elutions are specialized tests used in clinical blood banks. Examples of routine tests include ABO/Rh, antibody screen, antibody identification, and antiglobulin testing. Examples of other specialized tests used in blood banking include: treatment with thiol reagent, monocyte monolayer assay, enzyme treatment, and adsorptions. This procedure aids in the investigation of antibodies that are difficult to identify, distinguishing transfusion reactions, hemolytic disease of the fetus and newborn, and warm autoantibody workups.
Sources: en.wikipedia.org
Semax is a synthetic seven-amino-acid peptide derived from a fragment of corticotropin. It is used in Russia as a nasal preparation, while elsewhere it is studied as a research compound. It is not approved as a medicine in most countries.
Its sequence corresponds to the 4-10 region of corticotropin extended by three residues. This fragment lacks the region responsible for adrenal steroid release, so it is explored for neural rather than hormonal effects. The relationship explains the compound's classification among ACTH-derived peptides.
It holds approval in Russia for several neurological indications as a nasal spray or drop formulation. Regulatory agencies in the United States and the European Union have not approved it. Products sold elsewhere are generally labeled for research use only.
It is a synthetic peptide of seven amino acids. Its backbone corresponds to a fragment of adrenocorticotropic hormone extended at the carboxyl end. The material is distributed as a lyophilized solid for laboratory use.